Nordic Cancer Registries – an overview of their procedures and data comparability

­Eero Pukkala, Gerda Engholm, Lise Kristine Højsgaard Schmidt, +12

Acta Oncologica

Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer

Kaiyang Zhang, Erdoğan Pekcan Erkan, Sanaz Jamalzadeh, +14

Science Advances

Self-sample HPV Tests As an Intervention for Nonattendees of Cervical Cancer Screening in Finland: a Randomized Trial

Anni Virtanen, Pekka Nieminen, Tapio Luostarinen, +1

Cancer Epidemiology Biomarkers & Prevention

A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids

Wojciech Senkowski, Laura Gall-Mas, Matías Marín Falco, +26

Developmental Cell

Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma

Alexandra Lahtinen, Kari Lavikka, Anni Virtanen, +19

Cancer Cell

Evolutionary StatesPi3k InhibitorsEndocrine-related CancerTumor HeterogeneityHeterogeneity Analysis +12

Self‐sampling <i>versus</i> reminder letter: Effects on cervical cancer screening attendance and coverage in Finland

Anni Virtanen, Ahti Anttila, Tapio Luostarinen, +1

International Journal of Cancer

Trends in cancer survival in the Nordic countries 1990–2016: the NORDCAN survival studies

Frida E. Lundberg, Therése Andersson, Mats Lambe, +9

Acta Oncologica

Improving cervical cancer screening attendance in <scp>F</scp> inland

Anni Virtanen, Ahti Anttila, Tapio Luostarinen, +2

International Journal of Cancer

Self-sampling experiences among non-attendees to cervical screening

Anni Virtanen, Pekka Nieminen, Meri Niironen, +2

Gynecologic Oncology

Survey (Human Research)Cervical Cancer ScreeningCervical CancerCervical HealthCancer Screening +6

Vaginal Microbiota Composition Correlates Between Pap Smear Microscopy and Next Generation Sequencing and Associates to Socioeconomic Status

Seppo Virtanen, Tiina Rantsi, Anni Virtanen, +4

Scientific Reports